FOXO4-DRI releases p53 from this inhibitory interaction, enabling activation of downstream genes involved in mitochondrial apoptosis pathways
The body's metabolism adapts over time, and weight loss naturally slows after the initial months
Cabergoline is the preferred dopamine agonist owing to its long half-life, high efficacy and good tolerability (strong)
As with any IV therapy, vascular access, strict sterility, and the small but real possibility of an allergic or anaphylactic reaction apply
This article covers side effects reported in clinical trials, serious safety considerations still under study, and the practical clinical context for an informed conversation with a healthcare provider
Anxiety or psychological factors Starting a new medication, especially one that affects your appetite and how your body feels, can be stressful